From: Procalcitonin-guided diagnosis and antibiotic stewardship revisited
Type of infection | New studies since 2010? | Study design | PCT cut-off (μg/L) | Benefit of PCT use? | Main conclusions | Selected references since 2012 | |
---|---|---|---|---|---|---|---|
Pulmonary | AECOPD | yes | RCT (N = 120), meta-analysis | <0.25 | ++ | PCT reduces initiation of antibiotic treatment in the ED without adverse outcomes | |
Asthma | yes | RCT (N = 216) | <0.1–0.25 | ++ | PCT reduces initiation of antibiotic treatment in the ED without adverse outcomes | [89] | |
Bronchitis | yes (Registry) | RCT, real-life (Registry) | <0.1–0.25 | ++ | PCT reduces initiation of antibiotic treatment in the ED without adverse outcomes | [42] | |
Community-acquired pneumonia | yes | RCT, meta-analysis (N = 4467) real-life (Registry) | <0.1–0.25; 80–90% decrease | +++ | PCT shortens length of antibiotic therapy in the ED and hospital ward without adverse outcomes | [7] | |
Pulmonary fibrosis | yes | RCT (N = 78) | <0.25 | ++ | PCT reduces initiation of antibiotic treatment in the ED without adverse outcomes | [15] | |
Upper respiratory tract infections | no | RCT (N = 458, 702) | <0.1–0.25 | +++ | PCT reduces initiation of antibiotic treatment in primary care without adverse outcomes (non-inferiority) | ||
Heart | Congestive heart failure | yes | Observational, RCT (secondary analysis, N = 110) | <0.21–0.25 | ++ | PCT helps in identification of bacterial superinfection in acute heart failure, may be helpful in guiding antibiotic treatment | |
Endocarditis | no | Observational, meta-analysis | <0.5 | + | PCT is a predictor of poor outcome, diagnostic value similar to CRP | ||
Abdominal | Abdominal infections with peritonitis | yes | Observational | <0.5; 80% decrease | ++ | PCT-guided therapy was associated with lower antibiotic exposure with no difference in mortality | [66] |
Appendicitis | yes | Observational, meta-analysis | NR | + | PCT is a marker of complicated appendicitis, low value for diagnosing appendicitis | [92] | |
Pancreatitis | yes | RCT (N = 71) | <0.5 | ++ | PCT reduces antibiotic exposure compared to prophylactic antibiotic treatment without adverse outcomes | [65] | |
Urinary tract infections | yes | RCT (N = 125) | <0.25 | ++ | PCT reduces antibiotic exposure without adverse effects | [47] | |
Blood | Blood stream infection | yes | Observational | <0.25–1.47 | ++ | PCT levels correlate with risk for positive blood cultures | |
Neutropenia | yes | RCT (N = 62) | NR | – | PCT is not useful to manage antibiotic therapy, but PCT was a marker of bacteremia | [93] | |
Severe sepsis/shock | yes | RCT (N = 1575) | <0.5; 80% decrease | +++ | PCT reduces antibiotic exposure and 3 month mortality in the ICU | [30] | |
Postoperative | Postoperative abdominal infection | yes | Observational, meta-analysis | NR | + | Low PCT post-surgical ensure safe discharge, PCT is similar to CRP | |
Postoperative infections | yes | RCTs, Observational | <0.5–2.0 | ++ | Low PCT suggests absence of perioperative infection and enables early discharge | ||
Other | Arthritis | yes | Observational | <0.5 | + | PCT identifies infection in patients with rheumatoid arthritis | [94] |
Erysipelas | yes | Observational | <0.1 | + | PCT differentiates erysipelas from DVT | [81] | |
Meningitis | no | RCT, meta-analysis (N = 2058) | <0.5 | +++ | PCT reduces AB treatment during viral outbreak; serum PCT with CSF lactate reliably identifies bacterial meningitis |